Patent Assignment
Reel/Frame 047140/0290
Grant of Security Interest in Patent Rights
Recorded: 2018-09-24
Pages: 15
Assignor
TRIS PHARMA, INC.
Executed: 2018-09-21
Assignee
DEERFIELD MANAGEMENT COMPANY, L.P., AS THE AGENT
780 THIRD AVENUE, 37TH FLOOR, NEW YORK, NEW YORK, 10017
Covered Properties
(43)
A Pharmaceutical Composition Comprising Cyclosporin in Association with a Carrier in a Self-Emulsifying Drug Delivery System
Patent:
6,057,289 →
Application:
09/303,158 →
Self-Emulsifying Compositions for Drugs Poorly Soluble in Water
Patent:
6,436,430 →
Application:
09/459,299 →
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Abuse Resistant Opioid Drug-Ion Exchange Resin Complexes Having Hybrid Coatings
Formulations Containing an Ionic Mineral-Ion Exchange Resin Complex and Uses Thereof
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Novel Clonidine Formulation
Patent:
8,623,409 →
Application:
12/908,796 →
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Formulations Containing an Ionic Mineral-Ion Exchange Resin Complex and Uses Thereof
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Benzonatate Modified Release Solid Tablets and Capsules
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Methylphenidate Extended Release Chewable Tablet
Modified Release Formulations Containing Drug - Ion Exchange Resin Complexes
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Methylphenidate Extended Release Chewable Tablet
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Benzonatate Modified Release Solid Tablets and Capsules
Methylphenidate Extended Release Chewable Tablet
Methylphenidate Extended Release Chewable Tablet
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Benzonatate Modified Release Solid Tablets and Capsules
Methylphenidate Extended Release Chewable Tablet
Modified Release Formulations Containing Drug - Ion Exchange Resin Complexes
Modified Release Formulations Containing Drug - Ion Exchange Resin Complexes
Extended Release Amphetamine Compositions
Application:
15/258,695 →
Benzonatate Modified Release Solid Tablets and Capsules
Application:
15/482,201 →
Methylphenidate Extended Release Chewable Tablet
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Application:
15/706,234 →
Publication:
US 2018/0000954
Novel Clonidine Formulation
Application:
15/943,903 →
Publication:
US 2019/0015389
Methylphenidate Extended Release Chewable Tablet
Extended Release Amphetamine Tablets
Application:
62/562,464 →
Pharmaceutical Compositions Comprising a Floating Interpenetrating Polymer Network Forming System
Application:
62/607,129 →
Modified Release Drug Powder Composition Comprising Gasro-Retentive Raft Forming Systems Having Trigger Pulse Drug Release
Application:
62/607,141 →
Related Assignments
(20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 2, 2007
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA
Reel/Frame 019103/0030 →
Assignment of Assignor's Interest
Jul 1, 2008
From: MEHTA, KETAN; TU, YU-HSING; CHAUDHURI, ALIVIA; PERUMAL, ASHOK
To: TRIS PHARMA
Reel/Frame 021177/0143 →
Assignment of Assignor's Interest
Mar 20, 2009
From: MEHTA, KETAN; TU, YU-HSING; SHAH, MAHENDRA
To: TRIS PHARMA, INCORPORATED
Reel/Frame 022425/0345 →
Assignment of Assignor's Interest
Dec 10, 2010
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA, INC.
Reel/Frame 025470/0116 →
Assignment of Assignor's Interest
Apr 17, 2012
From: MEHTA, KETAN; TU, YU-HSING; PERUMAL, ASHOK
To: TRIS PHARMA, INC.
Reel/Frame 028056/0138 →
Assignment of Assignor's Interest
May 4, 2012
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA INC
Reel/Frame 028158/0060 →
Merger
Aug 1, 2012
From: PHARMASOLUTIONS, INC
To: TRIS PHARMA, INC
Reel/Frame 028698/0585 →
Assignment of Assignor's Interest
Jan 10, 2013
From: TU, YU-HSING; PERUMAL, ASHOK; MEHTA, KETAN
To: TRIS PHARMA, INC
Reel/Frame 029605/0799 →
Assignment of Assignor's Interest
Jan 22, 2013
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA, INC
Reel/Frame 029669/0483 →
Assignment of Assignor's Interest
Apr 17, 2013
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA, INC
Reel/Frame 030230/0123 →
Assignment of Assignor's Interest
Jul 23, 2013
From: MEHTA, KETAN; TU, YU-HSING; SHAH, MAHENDRA
To: TRIS PHARMA, INC
Reel/Frame 030852/0965 →
Assignment of Assignor's Interest
Aug 6, 2013
From: MEHTA, KETAN; TU, YU-HSING; PERUMAL, ASHOK
To: TRIS PHARMA, INC
Reel/Frame 030951/0411 →
Assignment of Assignor's Interest
Sep 3, 2013
From: MEHTA, KETAN; TU, YU-HSING; PERUMAL, ASHOK
To: TRIS PHARMA, INC
Reel/Frame 031124/0987 →
Assignment of Assignor's Interest
Oct 2, 2013
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA, INC
Reel/Frame 031329/0321 →
Assignment of Assignor's Interest
Oct 31, 2013
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA, INC
Reel/Frame 031521/0935 →
Assignment of Assignor's Interest
Jan 15, 2014
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA, INC
Reel/Frame 031976/0447 →
Patent Security Agreement
Sep 5, 2017
From: TRIS PHARMA, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 043761/0389 →
Notice of Release of Security Interest in Patents
Sep 25, 2018
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: TRIS PHARMA, INC.
Reel/Frame 047150/0169 →
Release of Security Interest
Sep 26, 2024
From: DEERFIELD MANAGEMENT COMPANY, L.P.
To: TRIS PHARMA, INC.; NEXTWAVE PHARMACEUTICALS INCORPORATED
Reel/Frame 069054/0362 →
Security Interest
Sep 26, 2024
From: TRIS PHARMA, INC.; PARK THERAPEUTICS, INC.
To: PROVIDENT BANK
Reel/Frame 069065/0576 →